Shares of obesity drug developer Aardvark Therapeutics (NASDAQ:AARD) closed 11% lower following the company's $94M initial public offering. Aardvark (NASDAQ:AARD) shares opened at $15.18 after being ...

Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Katie Price has revealed her son Harvey will start taking diet drug Ozempic due to worries over his increasing weight. The ...

Katie Price has revealed her fears for her son Harvey, 22, who has Prader-Willi syndrome and weighs 28 stone. She has puts ...

The TV personality's son has Prader-Willi syndrome, a very rare genetic disorder that causes him to be hungry all the time.

Harvey Price, the son of Katie Price and Manchester United footballer Dwight Yorke, lives with a condition known as Prader-Willi Syndrom ...

Katie Price has revealed her 22-year-old son Harvey is to begin Ozempic-style weight-loss injections in a bid to save his ...

Katie Price has opened up about Harvey's ongoing health issues as she has become forced to turn to weight loss injections for ...

The TV star has revealed her eldest son, who weighs 28 stone, will start a course of an Ozempic-style jab after consulting ...

Morgan Stanley, BofA Securities, Cantor and RBC Capital Markets are acting as joint book running managers for the offering.

Katie Price's son Harvey is set to start taking weight loss jabs. The 46-year-old actress is scared for her 22-year-old son, ...